Joe E. Kiani - 23 Sep 2025 Form 4 Insider Report for IRADIMED CORP (IRMD)

Reporting relationship: Director
Issuer ticker: IRMD
Reported as of: 23 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Sep 2025, 11:30:05 UTC
Prior SEC filing: 10 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Joe E. Kiani

Key filing fact

Joe E. Kiani filed Form 4 for IRADIMED CORP (IRMD) on 25 Sep 2025.

Key facts

This page summarizes Joe E. Kiani's Form 4 filing for IRADIMED CORP (IRMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Sep 2025, 11:30.

Change

Previous filing in this sequence was filed on 10 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001228621 Primary reporting owner

KIANI JOE E

Relationship: Director
Address: C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO
Signature: /s/ Joe E. Kiani
Signature date: 25 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRMD transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +2,095
Change %
Price: $0.000000
Shares after: 2,095
Date: 23 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,095
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

Footnote F2

The reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on September 23, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.